San Diego-dependent Viking Therapeutics marked alone as a significant competitor inside the weight loss drug marketplace in February immediately after revealing promising information from a mid-stage demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As wel